NOSEBLEED

Clinical trials for NOSEBLEED explained in plain language.

Never miss a new study

Get alerted when new NOSEBLEED trials appear

Sign up with your email to follow new studies for NOSEBLEED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Could a daily pill stop debilitating nosebleeds for HHT patients?

Symptom relief Ongoing

This study tests whether a low dose of the drug pazopanib, taken daily for 24 weeks, can reduce the severity and duration of nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT), a condition that causes frequent bleeding. About 70 participants will receive either…

Matched conditions: NOSEBLEED

Phase: PHASE2, PHASE3 • Sponsor: Cure HHT • Aim: Symptom relief

Last updated May 26, 2026 12:04 UTC

NOSEBLEED

Get alerted when new NOSEBLEED trials appear

Could a daily pill stop debilitating nosebleeds for HHT patients?